Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women. Pulmonary ...

Angiotensinogen is the sole precursor of angiotensin peptides and has a key role in the pathogenesis of hypertension. Zilebesiran, an investigational RNA interference therapeutic agent with a ...

Hypertension is one of the most prevalent non-transmittable diseases in the world, with 29% of the world's population expected to suffer from the condition by 2025. Despite substantial advances in ...

Laragh also played a pivotal part in elucidating the role of aldosterone in the pathogenesis of malignant hypertension and CV disease in general. [10,11] He was an outstanding clinician-scientist who ...

Of all derivatives, the TyG-WHtR index exhibited the strongest association with all-cause and cardiovascular mortality among patients with hypertension. The triglyceride–glucose (TyG) index and its ...

Expert Rev Cardiovasc Ther. 2012;10(11):1367-1373. The elderly merit special consideration for BP measurement. These hypertensive patients are prone to have autonomic failure with postural hypotension ...

Angiotensinogen plays a key role in hypertension pathogenesis. Zilebesiran, an RNA interference therapeutic agent that inhibits angiotensinogen production, is being studied for hypertension treatment.

Patients with MPNs are at increased risk for nonthrombotic conditions, including heart failure and pulmonary hypertension, necessitating improved understanding and management strategies. Pulmonary ...